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CHAPTER 4 
RESULTS  
4.1 Assessment of Cytotoxic Activity of H.erinaceus Extract 
4.1.1 Evaluation of optimum cell density for MTT Assay  
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide] assay 
was performed using a flat-bottomed 96-well plate of 0.37 cm
2
 growth area. The 
optimum cell density for the neural cell line, NG108-15 and lung fibroblast, MRC-5, 
was determined from the relation between the absorbance value and cell number per 
well. The plates were read using an ELISA microplate reader (EMax®, Molecular 
Device) at 540 nm, with a reference wavelength at 650 nm. The absorbance values used 
in calculations were the difference of measured absorbance at 540 nm and 650 nm. The 
cells were plated at cell number ranging from 1 000 – 20 000 cells per well and 
incubated for 50 hrs (the total duration of cytotoxicity assay).  
A linear relationship was observed between the absorbance value and the cell 
number per well in NG108-15 cell line, where the absorbance value increased with 
higher cell density (Figure 4.1). The linear relationship between the two variables was 
expressed in the equation y = 0.0001x + 0.1488 with the coefficient of determination, R
2
 
= 0.9716. To assess drug sensitivity in MTT assay, the cells should remain in 
exponential growth throughout the assay (Plumb, 1999). The optimum cell density for 
NG108-15 was chosen at 5 000 cells per well where the absorbance value stated around 
1. 
A linear relationship was similarly observed between the absorbance value and 
the cell number per well for MRC-5 cell line (Figure 4.2). The absorbance value 
increased with increasing cell density but the absorbance values were generally lower 
compared to the NG108-15 cell line. The linear relationship between the two variables 
was expressed in the equation y = 0.00003x + 0.0693 with the coefficient of 
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determination, R
2
 = 0.9542. As the MRC-5 cell line had a slower growth, the optimum 
cell density chosen was 10 000 cells per well. 
 
 
Figure 4.1: Relation between absorbance value and cell number in NG108-15 cells. The graph 
was plotted on the mean absorbance value ± SEM of two independent experiments carried out 
in triplicate. A linear relationship was observed between the absorbance value and cell number 
per well which can be expressed in the equation y = 0.0001x + 0.1488 (coefficient of 
determination, R
2
 = 0.9716).    
 
 
Figure 4.2: Relation between absorbance value and cell number in MRC-5 cells. The graph was 
plotted on the mean absorbance value ± SEM of two independent experiments carried out in 
triplicate. A linear relationship was observed between the absorbance value and cell number per 
well and expressed in the equation y = 0.00003x + 0.0693 (coefficient of determination, R
2
 = 
0.9542).  
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4.1.2 Cytotoxic activity of H.erinaceus extract in NG108-15 and MRC-5 cell lines 
The cytotoxicity of H.erinaceus aqueous extract was evaluated using the MTT 
assay. The cell viability of human lung fibroblast, MRC-5, and neural hybrid cell, 
NG108-15, was assessed after an overnight incubation with various concentrations of 
H.erinaceus aqueous extract. Cell viability, expressed as a percentage, was defined as 
the ratio of absorbance of treated cells to untreated cells. The cell viability of untreated 
control cells were scored as 100%.  
It was observed that varying concentrations of mushroom extracts had different 
effects on the cellular viability of MRC-5 fibroblast and NG108-15 neural cells for an 
incubation period of 24 hours (Figure 4.3). There was a concentration-dependent 
increase of cell viability in MRC-5 cells exposed to the extract concentrations from 0 – 
1000 µg/ml. Cell viability of MRC-5 treated with 10 µg/mL – 1000 µg/mL mushroom 
extract was significantly different (p < 0.05) compared to untreated control cells 
(Appendix D, Table 1 & 2, pp.130 ) 
At 1000 µg/mL, cell proliferation was observed at the end of 24 hr incubation, 
reflected by a 37.74% increment in cellular viability which was indicated as an increase 
in cell number. However, the cellular viability decreased at concentrations beyond 1000 
µg/mL. At 50 000 µg/mL, the cellular viability of MRC-5 was greatly reduced to 11.08 
± 0.58 %. The 50% inhibitory concentration (IC50) of H.erinaceus extract for MRC-5 
interpolated from the response curve was 34 094.57 ± 1199.80 µg/mL (Figure 4.3).  
The viability of NG108-15 cells was relatively constant when exposed to the 
mushroom extract at 0 – 1000 µg/mL. Further, there was no significant statistical 
difference between the groups at the range of concentrations tested (Appendix D, Table 
3 & 4, pp.130-131). However, the cellular viability similarly decreased when the 
concentration of extract was increased (above 1000 µg/mL). At 50 000 µg/mL, the 
cellular viability of NG108-15 was significantly reduced to 33.40 ± 4.44 %. The 
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average IC50 value of H.erinaceus extract for NG108-15 cell line was 14 446.07 ± 
1548.34 µg/mL.  
 
 
Figure 4.3: Cytotoxic effect of H.erinaceus extract in vitro. Each data point represents the mean 
cell viability ± SEM of three independent experiments carried out in triplicate. Untreated 
controls (0 mg/mL mushroom extract) were not plotted on log-scale graph. An asterisk (*) 
denotes a significant difference (p < 0.05) from the corresponding value for control. The 50% 
inhibitory concentration for the endpoint measured (IC50) was interpolated from the response 
curve using IDBS XLfit® Software. 
 
 
Table 4.1: IC50 values of H.erinaceus aqueous extract in MRC-5 and NG108-15 cell lines. 
Values given represent the mean ± SEM of three independent experiments carried out in 
triplicate.  
Cell Line IC50 (µg/mL) 
MRC-5 34 094.57 ± 1199.80 
NG108-15 14 446.07 ± 1548.34 
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4.2 Assessment of Neurite Outgrowth Stimulation in NG108-15 Cell Line 
4.2.1 Quantification of neurite-bearing cells in culture  
4.2.1.1 The effect of varying concentrations of NGF on neurite outgrowth 
stimulation 
The neurite outgrowth stimulation effect of NGF on neuronal hybrid NG108-15 
is presented in Figure 4.4. The neural cells NG108-15 were treated with NGF in the 
concentration range of 5 – 100 ng/mL. Percentage of neurite outgrowth activity was 
significantly higher (p < 0.05) than untreated control cells at all concentrations tested 
(Appendix D, Table 5 & 6, pp.131).  
It was observed that there was a dose-dependent increase in the neurite 
outgrowth stimulation activity in NG108-15 cells when subjected to 5 – 20 ng/mL NGF. 
The addition of 5 - 20 ng/mL NGF increased the percentage of neurite-bearing cells to 
28.2% - 33.7%, compared to untreated cells (23.5 ± 1.1 %). In this experimental model, 
the optimal concentration for maximal neurite stimulation (33.7 ± 2.9 %) was achieved 
at 20 ng/mL, attaining increment of 43.4% compared to untreated control.  
Further, the neurite outgrowth stimulation activity appeared to be reduced at 
concentrations higher than 20 ng/mL. The percentage of neurite-bearing cells at 10 – 
100 ng/mL was not significantly higher (p < 0.05) than the minimum NGF 
concentration tested (5 ng/mL), except for the optimal concentration (20 ng/mL).  
4.2.1.2 The effect of varying concentrations of H.erinaceus aqueous extract on 
neurite outgrowth stimulation 
The neurite outgrowth stimulation effect of H.erinaceus aqueous extract on 
neuronal hybrid NG108-15 is presented in Figure 4.5. The neural cells were treated 
with H.erinaceus extract in the concentration range of 1 – 500 µg/mL. Percentage of 
neurite outgrowth activity was significantly higher (p < 0.05) than untreated control 
cells at all concentrations tested (Appendix D, Table 7 & 8, pp.132). 
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Figure 4.4: Percentage of neurite-bearing cells in NG108-15 cells treated with NGF. Data 
shown are mean ± SEM of three independent experiments carried out in duplicate. An asterisk 
(*) denotes a significant difference (p < 0.05) from the corresponding value for control. A plus 
sign (+) denotes a significant difference (p < 0.05) in comparison to the 5 ng/mL treatment.  
 
 
 
Figure 4.5: Percentage of neurite-bearing cells in NG108-15 cells treated with H.erinaceus 
aqueous extract. Data shown are mean ± SEM of three independent experiments carried out in 
duplicate. An asterisk (*) denotes a significant difference (p < 0.05) from the corresponding 
value for control. A plus sign (+) denotes a significant difference (p < 0.05) in comparison to the 
1 µg/mL concentration.  
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The mushroom extract, when applied at 1 – 50 µg/mL, induced neurite 
outgrowth activity in NG108-15 cells in a dose-dependent manner (Figure 4.5). 
Addition of H.erinaceus extract at 10 µg/mL gave a near-maximal response with the 
presence of 36.0 ± 2.6 % neurite-bearing cells. A peak response (64.8% increment) was 
achieved with 36.5 ± 2.2 % neurite-bearing cells at a concentration of 50 µg/mL 
H.erinaceus extract. The percentage of neurite outgrowth activity of 10 µg/mL and 50 
µg/mL mushroom extract was significantly higher (p < 0.05) than the minimum 
mushroom extract concentration (1 µg/mL) tested. 
Higher concentrations of the mushroom extract did not improve the neurite 
stimulation activity of NG108-15. Instead, a decline in the percentage of neurite-bearing 
cells was observed. When the mushroom extract concentration was doubled (100 
µg/mL), the percentage of neurite-bearing cells was reduced to 32.2 ± 0.8 %. The 
neurite outgrowth stimulation activity reached a plateau at this concentration point 
despite increasing the extract concentration 5 fold to 500 µg/mL (32.0 ± 1.7 %). 
 
4.2.1.3 The effect of varying concentrations of H.erinaceus aqueous extract 
combined with 5, 10 and 20 ng/mL NGF on neurite outgrowth stimulation 
With the initial assessment of NGF on neurite outgrowth stimulation activity, 
the NG108-15 neural cells were subjected to 5, 10 and 20 ng/mL NGF combined with 
various concentrations of H.erinaceus aqueous extract. The concentration of 
H.erinaceus extract at 500 µg/mL was not further evaluated due to saturation of neurite 
stimulation activity at this concentration.  
The treatment of NG108-15 cells with 5 ng/mL NGF stimulated 25.5 ± 1.9 % 
cells to extend neurites (Figure 4.6). The highest percentage of neurite-bearing cells 
(27.9 ± 1.8 %) was achieved in the combined treatment of 50 µg/mL mushroom extract 
and 5 ng/mL NGF. Although an increment of 42.4% (compared to control) was attained 
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with this combined treatment, there was only 9.5% increment compared to 5 ng/mL 
NGF treatment. This combined treatment was not significantly different (p < 0.05) 
compared to 5 ng/mL NGF individually (Appendix D, Table 9 & 10, pp.132-133). The 
addition of varying concentrations of mushroom extract (1 – 100 µg/mL) in 
combination with 5 ng/mL NGF did not significantly (p < 0.05) enhance the neurite 
outgrowth stimulation activity compared to treatment with 5 ng/mL NGF individually.  
 
 
Figure 4.6: Percentage of neurite-bearing cells in NG108-15 cells treated with 5 ng/mL NGF 
and H.erinaceus aqueous extract. Data shown are mean ± SEM of three independent 
experiments carried out in duplicate. An asterisk (*) denotes a significant difference (p < 0.05) 
from the corresponding value for control. 
 
The treatment of 10 ng/mL NGF stimulated 35.5 ± 1.4 % cells to extend neurites, 
attaining 33.3% increment compared to untreated control cells (Figure 4.7). The 
addition of 1 µg/mL mushroom extract to 10 ng/mL NGF markedly enhanced the 
neurite outgrowth stimulation activity with 42.7 ± 2.3 % cells showing extensions. A 
comparable increment was also seen in the treatment of 10 µg/mL mushroom extract 
added to 10 ng/mL NGF, with 42.3 ± 1.9 % of cells bearing neurite. The effect of 
neurite outgrowth stimulation was enhanced 1.2-fold in these combined mixtures when 
compared to 10 ng/mL NGF applied individually. The percentage of neurite outgrowth 
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stimulation activity in these combined mixtures was significantly higher (p < 0.05) 
compared to other combined concentrations tested (Appendix D, Table 11 &12, pp.133). 
When the mushroom extract concentration was increased to 50 µg/mL, the 
enhancement of neurite outgrowth stimulation activity by the combined mixture was 
still observed but less pronounced. The percentage of neurite-bearing cells was 39.0 ± 
1.0 % when the extract concentration was increased to 50 µg/mL. In this treatment, the 
neurite extension activity was enhanced 9.9% compared to 10 ng/mL NGF treatment 
alone. This enhancement was significantly different (p < 0.05) compared to 10 ng/mL 
NGF treatment. However, the enhancement of neurite outgrowth stimulation activity 
was not observed when the mushroom extract was further increased. The addition of 
100 µg/mL mushroom extract to 10 ng/mL NGF reduced 2.3% of neurite outgrowth 
activity compared to 10 ng/mL NGF treatment alone. The percentage of neurite-bearing 
cells of this combined mixture (100 µg/mL mushroom extract + 10 ng/mL NGF) was 
not significantly different (p < 0.05) compared to 10 ng/mL NGF treatment alone. 
 
 
Figure 4.7: Percentage of neurite-bearing cells in NG108-15 cells treated with 10 ng/mL NGF 
and H.erinaceus aqueous extract. Data shown are mean ± SEM of three independent 
experiments carried out in duplicate. An asterisk (*) denotes a significant difference (p < 0.05) 
from the corresponding value for control. A plus sign (+) denotes a significant difference (p < 
0.05) in comparison to the 0 µg/mL mushroom extract concentration (with 10 ng/mL NGF 
only).  
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The treatment of NG108-15 cells with 20 ng/mL NGF stimulated 31.6 ± 2.9 % 
neurite-bearing cells, with 44.0% increment compared to untreated control cells (Figure 
4.8). The addition of varying concentrations of mushroom extract (1 – 100 µg/mL) in 
combination with 20 ng/mL NGF did not significantly (p < 0.05) enhance the neurite 
outgrowth stimulation activity compared to treatment with 20 ng/mL NGF individually. 
Addition of 1 µg/mL and 10 µg/mL mushroom extract to 20 ng/mL NGF slightly 
increased the neurite outgrowth stimulation activity, with 32.2 ± 3.2 % and 32.6 ± 3.7 % 
neurite-bearing cells induced respectively. The addition of these combined mixture 
merely increased the neurite-bearing cells by 1.7% (1 µg/mL mushroom extract) and 3.2% 
(10 µg/mL mushroom extract) compared to 20 ng/mL NGF treatment alone.  
When the mushroom extract concentration was increased (50 µg/mL – 100 
µg/mL), the neurite outgrowth stimulation activity was reduced. The addition of 50 
µg/mL mushroom extract to 20 ng/mL NGF reduced the percentage of neurite-bearing 
cells by 3.8% (30.4 ± 2.3 %) compared to 20 ng/mL NGF treatment alone. The neurite 
outgrowth stimulation activity further declined by 7.0% (29.4 ± 2.2 %) when the 
mushroom extract concentration was increased to 100 µg/mL. However, the decline of 
these treatment was not significantly different (p < 0.05) compared to 20 ng/mL NGF 
treatment (Appendix D, Table 13 & 14, pp.134). 
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Figure 4.8: Percentage of neurite-bearing cells in NG108-15 cells treated with 20 ng/mL NGF 
and H.erinaceus aqueous extract. Data shown are mean ± SEM of three independent 
experiments carried out in duplicate. An asterisk (*) denotes a significant difference (p < 0.05) 
from the corresponding value for control. 
 
 
4.2.1.4  Morphology of NG108-15 cells under different treatment conditions 
NG108-15 is a somatic cell hybrid from a cross between mouse N18TG2 
neuroblastoma cells with rat C6-BU-1 glioma cells. In normal untreated cultures, the 
cells appeared to be flat, round, growing in clusters and loosely adherent on cell culture 
surface. The poly-D-lysine coating served as a neutral substratum where the cells were 
observed to attach within the first hour of plating and this minimized the clustering of 
cells. Untreated control cells had short cellular processes but mostly did not reach the 
criterion length of one cell body diameter to be scored as a neurite-bearing cell.  
When H.erinaceus aqueous extract was applied individually or in combination 
with NGF, visible neurite outgrowth was induced in the neuroblastoma-glioma hybrid 
NG108-15. Diverse and extensive neurite formation was observed in differentiated cells. 
Cells expressing ‘slow-onset’ neurites formed long, smooth, cable-like neurite 
extensions with a definite single axis of polarity (usually unipolar or bipolar). These 
cells usually appear as singlets, doublets or clusters of cells with neurite length of 
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several hundred µm (Figure 4.9a). On the other hand, cells expressing ‘rapid-onset’ 
neurites formed exuberant multipolar outgrowth with extensive branching. These 
neurite extensions were usually beaded with relatively short neurite length compared to 
‘slow-onset’ neurites (Figure 4.9b). It was observed that neurite extensions became 
fused (fasciculation) and formed thick neurite bundles in some ‘rapid-onset’ neurites, 
especially in cells growing in clusters (Figure 4.9c). 
Both distinct neurite outgrowth mode – ‘rapid-onset’ and ‘slow-onset’, was 
observed in mushroom-treated and NGF-treated cells. The cells exhibited extensive 
neurite networks with higher percentage of neurite-bearing cells present in culture when 
treated with a combination of H.erinaceus extract and 10 ng/mL NGF (Figure 4.10). 
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Figure 4.9: The prototypical slow-onset and rapid-onset neurite patterns observed in NG108-15 
cells. (a) Cells expressing ‘slow-onset’ neurites formed long, unipolar, cable-like extensions. (b) 
Cells expressing ‘rapid-onset’ neurites formed short, irregular, branched neurites. (c) Neurite 
fasciculation (indicated by arrow) observed in culture. Scale bar = 100 µm.   
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Figure 4.10: Representative images showing the morphology of NG108-15 cells treated with NGF, H.erinaceus aqueous extract or both.. The control group refers to 
untreated cells. The black arrows denote the presence of neurites in respective treatments. The prototypical slow-onset and rapid-onset neurite patterns are observed 
in cultures. Scale bar = 100 µm.   
Control 20 ng/mL NGF  
50 µg/mL H.erinaceus extract  1 µg/mL H.erinaceus extract + 10 ng/mL NGF  
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4.2.2 Measurement of extracellular NGF levels in cell culture  
4.2.2.1 The extracellular NGF levels in NG108-15 cell line treated with varying 
concentrations of H.erinaceus aqueous extract  
The aqueous extract of H.erinaceus was shown to induce neurite outgrowth 
stimulation activity in NG108-15 cells (Figure 4.5). As the neuroactive compounds in 
the H.erinaceus mushroom – hericenones and erinacines, were reported to induce NGF 
synthesis in mouse astroglial cells in vitro (Ma et al., 2010), the extracellular NGF level 
in NG108-15 cells treated with varying concentrations of H.erinaceus extract was 
measured using enzyme-linked immunosorbent assay (ELISA).  
The NGF standard curve ranging 3.9 – 250 pg/mL was generated as a linear 
curve (Appendix C, pp.129). The NGF concentration (pg/mL) in test samples was 
interpolated from the standard curve using the average absorbance value of triplicate 
wells. The NGF level in NG108-15 cells treated with various concentrations of 
H.erinaceus aqueous extract measured using ELISA is presented in Figure 4.11.  
 
 
Figure 4.11: The extracellular NGF levels in NG108-15 cells treated with H.erinaceus aqueous 
extract. Data shown are mean ± SEM of two experiments carried out in triplicate wells. An 
asterisk (*) denotes a significant difference (p < 0.05) from the corresponding value for control. 
A plus sign (+) denotes a significant difference (p < 0.05) in comparison to the 1 µg/mL 
mushroom extract concentration. 
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It was observed that there was a significant increase (p < 0.05) in the NGF 
concentration when the cells were treated with 1 – 50 µg/mL H.erinaceus aqueous 
extract compared to untreated control (Appendix D, Table 15 & 16, pp.134). The 
addition of 1 µg/mL mushroom extract in the cells increased the NGF concentration by 
50.8% (37.12 ± 0.03 pg/mL) compared to untreated control cells (24.62 ± 1.17 pg/mL). 
When 10 µg/mL of mushroom extract was applied, the amount of NGF was slightly 
reduced to 36.58 ± 0.27 pg/mL but this reduction was not statistically significant (p < 
0.05). Maximum NGF secretion in the cell culture supernatant (45.67 ± 0.79 pg/mL) 
was observed in NG108-15 cells treated with 50 µg/mL H.erinaceus aqueous extract. 
As mentioned in section 4.2.1.2, maximal neurite outgrowth stimulation activity (36.5 ± 
2.2 % neurite-bearing cells) was similarly observed at this treatment group.  
A steep decline was observed in the NGF concentration in the cell culture 
supernatant when the concentration of mushroom extract was further increased beyond 
the optimal concentration (50 µg/mL). The amount of NGF was reduced to 29.94 ± 1.28 
pg/mL when the cells were applied with 100 µg/mL H.erinaceus aqueous extract. When 
the mushroom extract was further increased to 500 µg/mL, the NGF concentration was 
drastically reduced to 9.07 ± 0.40 pg/mL, stating a 63.1% reduction compared to 
untreated control cells. The amount of NGF in the culture supernatant was significantly 
reduced (p < 0.05) when treated with 500 µg/mL H.erinaceus aqueous extract. 
 
4.2.2.2 The extracellular NGF levels in NG108-15 cell line treated with varying 
concentrations of H.erinaceus aqueous extract combined with 10 ng/mL 
NGF  
Earlier morphological differentiation studies showed that the combination of 10 
ng/mL NGF and H.erinaceus aqueous extract could enhance neurite outgrowth 
stimulation activity in NG108-15 cells. Thus, this combined treatment group was 
chosen to measure the NGF concentration present in the cell culture supernatant.  
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The NGF level in NG108-15 cells treated with various concentrations of 
H.erinaceus aqueous extract combined with 10 ng/mL NGF is presented in Figure 4.12. 
The NGF concentration in the cell culture supernatant of NGF and/or mushroom 
extract-treated cells was significantly higher (p < 0.05) than untreated control cells 
(Appendix D, Table 17 & 18, pp.135). When the cells were treated with 10 ng/mL NGF 
for 48 hr, 661.35 ± 32.21 pg/mL NGF was detected to be present in the cell culture 
supernatant. However, when 1 µg/mL H.erinaceus aqueous extract combined with 10 
ng/mL NGF was applied to the cells, there was a 281.5% increment (2523.23 ± 160.97 
pg/mL) in the NGF concentration compared to 10 ng/mL NGF. A comparable 
increment (278.4%) of NGF concentration (2502.37 ± 94.28 pg/mL) was observed 
when the mushroom extract was increased to 10 µg/mL. The NGF concentration was 
significantly increased (p < 0.05) when the cells were treated with 1 – 10 µg/mL 
H.erinaceus aqueous extract combined with 10 ng/mL NGF. There was no significant 
difference (p < 0.05) between these two treatment groups.  
Further, the NGF concentration was markedly enhanced when the H.erinaceus 
aqueous extract was increased to 50 – 100 µg/mL in the combined mixture (Figure 
4.12). The addition of 50 µg/mL mushroom extract and 10 ng/mL NGF to the neural 
cells increased the NGF concentration by 18700.3 % (3175.02 ± 28.90 pg/mL) 
compared to untreated control cells. When the mushroom extract was increased to 100 
µg/mL in the combined mixture, there was a slight decrease of NGF concentration 
(2978.32 ± 81.82 pg/mL) in the cell culture supernatant. However, the decrease was not 
statistically significant (p < 0.05) and there was no significant difference between these 
two treatment groups. 
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Figure 4.12: The extracellular NGF levels in NG108-15 cells treated with H.erinaceus aqueous 
extract combined with 10 ng/mL NGF. Data shown are mean ± SEM of three experiments 
carried out in triplicate wells. An asterisk (*) denotes a significant difference (p < 0.05) from the 
corresponding value for control. A plus sign (+) denotes a significant difference (p < 0.05) in 
comparison to the 0 µg/mL mushroom extract concentration (with 10 ng/mL NGF only).  
 
4.2.3 Immunofluorescence staining of neurofilament 200 kDa subunit  
As mentioned in earlier sections, the NG108-15 cells were able to extend 
neurites when treated with NGF and H.erinaceus aqueous extract either individually or 
in combination. Neurofilament 200 kDa subunit protein is an intermediate filament 
specifically expressed in neurons and often used as an axonal marker. Thus, the cells 
were stained for neurofilament to confirm the morphological extensions were of 
neuronal origin.  
Untreated control cells remained undifferentiated throughout the 48 hr 
incubation period. The cells were flat, round in shape and lack of neurite extensions. 
However, these undifferentiated cells stained positively for neurofilament (Figure 4.13). 
Cells treated with H.erinaceus aqueous extract and/or NGF exhibited neuron-like 
morphology with extensive cellular processes. These differentiated cells similarly 
stained positive for neurofilament, indicating the visible neurite extensions were of 
neuronal origin. 
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Figure 4.13: Immunocytochemical staining of NG108-15 cells for neurofilament 200 kDa 
subunit. The neuronal cells were labelled with antibodies against neurofilament followed by 
FITC (shown in green). Cell nuclei were counterstained with DAPI (blue) to facilitate cell 
counting. The neurites stained positive for neurofilament-200 (white arrows) after treated with 
H.erinaceus extract, NGF, or both. Scale bar = 50 µm. 
  
Control 50 µg/mL H.erinaceus extract 
1 µg/mL H.erinaceus + 10 ng/mL NGF  20 ng/mL NGF  
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4.3 Assessment of Neuroprotective Activity of H.erinaceus Extract on NG108-
15 Cell Line 
4.3.1 Assessment of cellular viability using MTT assay 
4.3.1.1 Evaluation of cytotoxic activity of H2O2 in NG108-15 cells 
The neural cells NG108-15 were subjected to various concentrations of H2O2 (0 
– 500 µM) for 2 - 24 hr to evaluate the cytotoxic activity of H2O2. The viability of 
untreated control cells at each incubation time was scored as 100%. 
The cellular viability was greatly influenced by two factors: H2O2 concentration 
and incubation period. From Table 4.2, it was shown that H2O2 at low concentrations 
(0.5 – 10 µM) did not greatly affect the cellular viability even with increased incubation 
period up to 24 hr. The cellular viability was maintained at 90% and above when 
incubated with 0.5 – 10 µM H2O2 for 2 – 24 hr. When 0.5 – 10 µM H2O2 was applied to 
the cells, the viability was not statistically different (p < 0.05) compared to the 
corresponding untreated control at each incubation period except for 4 hr treatment 
group (Appendix D, Table 19-30, pp.135-140). 
 When the cells were subjected to 50 µM H2O2, the cellular viability was 
reduced to 84.27 ± 4.36 % (2 hr incubation) and further dropped to 36.98 ± 1.44 % after 
24 hr incubation. At 50 µM H2O2, the reduction of cellular viability was statistically 
significant (p < 0.05) at all incubation time except for 8 hr treatment group. The neural 
cells were 54.89 – 60.50 % viable when incubated with 100 µM H2O2 for 2 – 4 hr, but 
viability was drastically reduced (13.04 – 35.74 %) when the incubation period was 
further increased (6 – 24 hr). The cellular viability significantly declined (p < 0.05) 
when the H2O2 concentration was further increased to 250 – 500 µM. 
From the evaluation of cytotoxic activity of H2O2, the treatment condition of 100 
µM H2O2 and 2 hr incubation was chosen to further evaluate the neuroprotective 
activity of H.erinaceus aqueous extract.  
  
Table 4.2: Cellular viability of NG108-15 cells treated with varying concentrations of H2O2 at different incubation period. Untreated cells were taken 
as control and cellular viability was scored as 100%. Values given represent the mean ± SEM of two independent experiments carried out in duplicate. 
Means with different letters in a same column are significantly different (p < 0.05). 
 
H2O2 Concentration 
(µM) 
Cell Viability (%) 
2 hr 4 hr 6 hr 8 hr 12 hr 24 hr 
0 100.00 ± 4.98
d 
100.00 ± 2.32
d 
100.00 ± 4.54
e 
100.00 ± 4.44
de 
100.00 ± 2.63
d 
100.00 ± 3.64
d 
0.5 94.04 ± 4.87
d 
103.82 ± 3.78
d 
91.46 ± 4.59
de 
99.32 ± 1.84
de 
95.91 ± 7.14
d 
94.74 ± 2.36
d 
1 102.30 ± 7.22
d 
99.45 ± 3.67
d 
89.13 ± 2.82
d 
88.96 ± 4.00
c 
98.38 ± 8.75
d 
97.18 ± 1.75
d 
5 94.82 ± 3.89
d 
97.79 ± 4.31
d 
94.33 ± 6.84
de 
107.33 ± 2.93
e 
94.93 ± 7.44
d 
99.18 ± 6.07
d 
10 100.73 ± 4.32
d 
112.56 ± 3.38
e 
93.96 ± 4.32
de 
104.40 ± 1.95
e 
102.85 ± 2.35
d 
95.03 ± 1.85
d 
50 84.27 ± 4.36
c 
78.04 ± 4.86
c 
61.40 ± 9.82
c 
92.20 ± 9.67
cd 
66.25 ± 2.81
c 
36.98 ± 1.44
c 
100 54.89 ± 4.40
b 
60.50 ± 3.82
b 
32.56 ± 4.99
b 
35.74 ± 5.46
b 
19.98 ± 3.24
b 
13.04 ± 1.29
b 
250 19.03 ± 2.36
a 
5.68 ± 0.87
a 
8.75 ± 0.71
a 
10.41 ± 3.81
a 
2.09 ± 0.40
a 
2.42 ± 0.32
a 
500 16.57 ± 1.54
a 
3.77 ± 0.32
a 
9.12 ± 0.61
a 
10.20 ± 3.56
a 
1.79 ± 0.23
a 
2.26 ± 0.30
a 
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4.3.1.2 Cellular viability of NG108-15 cells pre-treated with H.erinaceus extract prior 
to H2O2-induced oxidative stress  
To assess the neuroprotective effect of H.erinaceus extract against oxidative stress, 
pre-treatment and co-treatment of extract application were studied. In pre-treatment 
experiments, NG108-15 cells were incubated with extract prior to the introduction of 
oxidative stress. The neural cells were treated with H.erinaceus aqueous extract at varying 
concentrations for 2 hr and 24 hr respectively prior subjected to 100 µM H2O2 for 2 hr 
(Figure 4.14). The cellular viability of untreated control cells was scored as 100%. All 
treatment groups were significantly different (p < 0.05) from untreated control (Appendix 
D, Table 31 - 34, pp.141 - 142).  
The viability of NG108-15 cells decreased to ~ 60% (57.11% – 61.04%) when 
subjected to 100 µM H2O2 for 2 hr. The pre-treatment of H.erinaceus extract (1 – 1000 
µg/mL) for 2 hr did not improve cellular viability and there was no significant difference (p 
< 0.05) between the treated cells and the non-treated cells. The cellular viability remained 
within the range of 58.00% - 63.48%. 
The cells were then further incubated with the mushroom extract for 24 hr in hoping 
for cellular protection upon longer incubation period. However, the viability of extract-
treated cells was not improved with extended hours of extract pre-treatment. The viability 
of treated cells was not significantly different (p < 0.05) from non-treated cells. (Appendix 
D, Table 33 & 34, pp.142). Further, cells incubated with high concentrations of extract (500 
– 1000 µg/mL) for 24 hr showed a significant reduction in cellular viability (38.67 – 
42.01 %) compared to lower concentrations (< 500 µg/mL).  
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Figure 4.14: Cellular viability of NG108-15 cells pre-treated with H.erinaceus aqueous extract 
prior to H2O2-induced oxidative stress. Untreated control cells were set at 100% viability. All 
treatment groups were significantly different (p < 0.05) from untreated control. An asterisk (*) 
denotes a significant difference (p < 0.05) from the corresponding value for 0 µg/mL extract 
concentration (treated with 100 µM H2O2 only). 
 
4.3.1.3 Cellular viability of NG108-15 cells co-treated with H.erinaceus extract and 
H2O2  
To assess the neuroprotective effect of H.erinaceus extract in the presence of H2O2, 
co-treatment of extract application was studied. The mushroom extract was added 
simultaneously with 100 µM H2O2 in NG108-15 cells and incubated for 2 hr (Figure 4.15). 
The cell viability of untreated control cells was scored as 100%. All treatment groups were 
significantly different (p < 0.05) from untreated control (Appendix D, Table 35 & 36, 
pp.143). 
The cell viability of NG108-15 was reduced to 56.67 ± 4.23 % when subjected to 
100 µM H2O2 for 2 hr. The simultaneous addition of H.erinaceus extract within the 
concentration range of 1 – 1000 µg/mL did not improve cell viability in the 2 hr oxidative 
assault. The cell viability declined within the range of 51.49 – 59.68 % when co-incubated 
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with H.erinaceus extract and H2O2 for 2 hr. The cell viability of extract-treated groups was 
not statistically different (p < 0.05) from cells not treated with the extract (0 µg/mL).  
 
 
Figure 4.15: Cellular viability of NG108-15 cells co-treated with H.erinaceus aqueous extract and 
H2O2. Untreated control cells were set at 100% viability. All treatment groups were significantly 
different (p < 0.05) from untreated control.  
 
4.3.2 Assessment of cellular viability using trypan blue exclusion assay  
4.3.2.1 Cellular viability of NG108-15 cells pre-treated with H.erinaceus extract prior 
to H2O2-induced oxidative stress  
The neuroprotective activity of H.erinaceus extract was evaluated using trypan blue 
exclusion assay. NG108-15 cells were pre-treated with varying concentrations of extract for 
2 hr and 24 hr prior subjected to 100 µM H2O2 for 2 hr (Figure 4.16). All treatment groups 
were significantly different (p < 0.05) from untreated control (Appendix D, Table 37 - 40, 
pp.144 - 145).  
The cell viability of NG108-15 decreased to 56.8 - 61.5 % when subjected to 100 
µM H2O2 for 2 hr. Pre-incubation of H.erinaceus extract (1 – 1000 μg/mL) for 2 hr did not 
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improve cell viability of NG108-15; there was no significant difference (p < 0.05) between 
extract treated and non-extract treated cells. The cell viability remained within the range of 
50.4 – 59.9%. However, the extended incubation period of H.erinaceus (24 hr) significantly 
improved the cellular viability of NG108-15. When the cells were pre-incubated with 1 – 
50 µg/mL extract for 24 hr, the cellular viability was increased to 74.6 – 79.2 %. The pre-
treatment of H.erinaceus extract at 100 µg/mL gave the highest level of cellular protection 
with cell viability maintained at 80.5 ± 3.4 %. This treatment increased the cell viability by 
30.9% compared to cells without extract treatment (0 µg/mL). Cell viability of NG108-15 
treated with 100 µg/mL H.erinaceus extract prior H2O2 assault was significantly different 
(p < 0.05) from all other extract-treated groups except 10 µg/mL treatment.  
The cell viability of NG108-15 cells improved, though at a lesser degree, when the 
concentration of H.erinaceus extract was further increased. The cell viability was 
maintained at 72.6 – 75.1 % when pre-treated with 500 – 1000 µg/mL extract. There was 
no significant difference (p < 0.05) between these two treatment groups.  
  
75 
 
Figure 4.16: Cellular viability of NG108-15 cells pre-treated with H.erinaceus aqueous extract 
prior to H2O2-induced oxidative stress. All treatment groups were significantly different (p < 0.05) 
from untreated control. An asterisk (*) denotes a difference (p < 0.05) from the corresponding value 
in 0 µg/mL extract concentration (treated with 100 µM H2O2 only). A hash sign (#) denotes a 
significant difference (p < 0.05) between the marked treatment groups.  
 
4.3.2.2 Cellular viability of NG108-15 cells co-treated with H.erinaceus extract and 
H2O2  
Trypan blue exclusion assay was similarly used to assess neuroprotective activity of 
H.erinaceus extract when co-incubated with 100 µM H2O2 for 2 hr (Figure 4.17). All 
treatment groups were significantly different (p < 0.05) from untreated control cells 
(Appendix D, Table 41 & 42, pp.145).  
The cell viability of NG108-15 was reduced to 66.60 ± 4.56 % when subjected to 
100 µM H2O2 for 2 hr. When varying concentrations of mushroom extract were added 
simultaneously with H2O2 through the incubation period, significant improvement in 
cellular viability was not observed. The cell viability declined within the range of 65.86 – 
68.87 % when treated with 1 – 50 µg/mL extract together with H2O2 for 2 hr. There was no 
significant difference (p < 0.05) among these treatment groups.  
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Improvement in cellular viability was not observed when the mushroom extract was 
further increased to 100 – 1000 µg/mL. Instead, a slight decrease was observed in cell 
viability (57.13 – 61.94 %). There was no significant difference (p < 0.05) among these 
concentration treatments. The decline in cell viability (57.13 ± 6.29 %) when treated with 
1000 µg/mL extract was significantly different (p < 0.05) compared to cells not treated with 
extract (0 µg/mL).  
 
 
Figure 4.17: Cellular viability of NG108-15 cells co-treated with H.erinaceus aqueous extract and 
H2O2. Data shown are mean ± SEM of two experiments carried out in duplicate wells. All treatment 
groups were significantly different (p < 0.05) from untreated control. An asterisk (*) denotes a 
significant difference (p < 0.05) from 0 µg/mL extract concentration (treated with 100 µM H2O2 
only). 
 
4.3.3 Assessment of apoptosis using TUNEL assay 
4.3.3.1 Evaluation of apoptotic cells in NG108-15 cells pre-treated with H.erinaceus 
aqueous extract  
The pre-treatment of H.erinaceus extract (100 µg/mL) for 24 hr prior H2O2 
exposure showed significant protection when assessed using trypan blue exclusion assay. 
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This treatment was further evaluated to assess the neuroprotective activity in H.erinaceus 
extract using TUNEL assay. The TUNEL method identifies apoptotic cells present in the 
cell culture.  
NG108-15 cells were treated with 100 µg/mL extract (24 hr), 100 µM H2O2 (2 hr), 
or in pre-treatment mode [100 µg/mL extract (24 hr) followed by 100 µM H2O2 (2 hr)]. 
When the cells were incubated with 100 µg/mL H.erinaceus extract for 24 hr, 11.89 ± 1.81 % 
apoptotic cells were present in the culture (Table 4.3). A higher fraction of apoptotic cells 
(17.68 ± 3.41 %) was detected when the cells were incubated with 100 µM H2O2 for 2 hr. 
Pre-incubation of H.erinaceus aqueous extract for 24 hr slightly reduced the apoptotic cells 
to 15.85 ± 3.05 %. However, this reduction was not significantly different (p < 0.05) when 
compared to H2O2 treatment alone. All treatment groups were significantly different (p < 
0.05) compared to the untreated control (Appendix D, Table 43 & 44, pp.146). 
A positive control for TUNEL was prepared using bovine DNase I (nuclease) to 
induce DNA strand breaks (Figure 4.18). The apoptotic cells in the positive control slide 
were intensely stained green and showed typical apoptotic features such as cellular 
fragmentation. Similar morphological patterns were observed in cells treated with H2O2 
alone and pre-treatment of extract followed by H2O2. In cells treated with extract alone, the 
apoptotic cells were moderately stained green. It was observed that there was a lower 
occurrence of cellular fragmentation in this treatment group.  
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Table 4.3: Evaluation of apoptotic cells in NG108-15 cells subjected to different treatments using 
TUNEL assay. Cells were grown in Lab-Tek
TM
 8-well chamber slide and treated with extract, H2O2 
or both in succession. Values given represent the mean ± SEM of two independent experiments 
carried out in duplicate. Means with different letters in a same column are significantly different (p 
< 0.05). 
Treatment Apoptotic Cells (%) 
Control 2.1 ± 0.6
a
 
100 µg/mL extract 11.9 ± 1.8
b
 
100 µM H2O2 17.7 ± 3.4
c
 
100 µg/mL extract – 100 µM H2O2 15.9 ± 3.1
bc
 
* Values are given in 1 decimal point as counting of TUNEL-positive cells was done manually. 
 
 
  
  
Figure 4.18: Morphology of apoptotic cells stained using TUNEL assay. The TUNEL-positive 
control was stained using DNase I provided in the kit. Apoptotic cells were stained green (avidin-
FITC) and display morphological properties such as cellular condensation and fragmentation. The 
white arrows denote the presence of apoptotic cells in each photo. Scale bar = 100 µm. 
  
100 µg/mL extract – 100 µM H2O2  100 µg/mL H.erinaceus extract 
100 µM H2O2  TUNEL-positive control  
